Kevin M. Brennan

Insider Reports History

Location
Waltham, MA
Signature
/s/ Kevin Brennan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin M. Brennan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Xilio Therapeutics, Inc. SVP, FINANCE AND ACCOUNTING Restricted Stock Units 10,000 $15,600 $1.04 01 Jan 2026 Direct
Xilio Therapeutics, Inc. SVP, FINANCE AND ACCOUNTING Common Stock 6,371 $4,097 $0.6432 02 Jan 2026 Direct
Xilio Therapeutics, Inc. SVP, FINANCE AND ACCOUNTING Stock Option (right to buy) 95,221 31 Dec 2025 Direct

Insider Reports Filed by Kevin M. Brennan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XLO Xilio Therapeutics, Inc. 31 Dec 2025 4 -$1,174 4 SVP, FINANCE AND ACCOUNTING 05 Jan 2026, 16:30
XLO Xilio Therapeutics, Inc. 21 Nov 2025 7 $0 4 SVP, FINANCE AND ACCOUNTING 25 Nov 2025, 16:10
XLO Xilio Therapeutics, Inc. 01 Jan 2025 4 -$1,774 4 SVP, FINANCE AND ACCOUNTING 03 Jan 2025, 16:15
XLO Xilio Therapeutics, Inc. 01 Oct 2024 1 $0 4 SVP, FINANCE AND ACCOUNTING 02 Oct 2024, 17:15
XLO Xilio Therapeutics, Inc. 01 May 2024 1 $0 4 SVP, FINANCE AND ACCOUNTING 03 May 2024, 16:10
XLO Xilio Therapeutics, Inc. 01 Jan 2024 1 $0 4 SVP, FINANCE AND ACCOUNTING 03 Jan 2024, 16:15
XLO Xilio Therapeutics, Inc. 16 Aug 2023 1 $0 4 SVP, FINANCE AND ACCOUNTING 18 Aug 2023, 20:35
XLO Xilio Therapeutics, Inc. 01 Apr 2023 1 $0 4 SVP, FINANCE AND ACCOUNTING 03 Apr 2023, 16:11
XLO Xilio Therapeutics, Inc. 30 Mar 2023 0 $0 3 SVP, FINANCE AND ACCOUNTING 03 Apr 2023, 16:07